Hospira Recalls 5% Dextrose and 0.9% Sodium Chloride Injection Bags
Hospira is recalling 340,272 bags of 5% Dextrose and 0.9% Sodium Chloride Injection due to potential punctures that may compromise sterility and cause leaks.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. Per the rubric, FDA Class II recalls involving significant injury/property-damage reports or structural defects (such as container integrity issues leading to sterility loss) are categorized as Severe (Score 4).
Plain-English summary
Hospira Inc. is recalling 340,272 bags of 5% Dextrose and 0.9% Sodium Chloride Injection, USP, 1000 mL containers. The affected product is identified by NDC 0409-7941-09 and includes lots 32-104-JT (exp. 08/15), 34-136-JT (exp. 10/15), and 36-092-JT (exp. 12/15).
The recall was initiated due to a lack of assurance of sterility. Potential punctures through the overwrap and primary container may result in IV bag leaks, which could compromise the sterility of the solution. The product was distributed nationwide, as well as in Puerto Rico and the U.S. Virgin Islands.
Healthcare providers and patients should stop using the affected lots and contact Hospira Inc. for further instructions. The FDA has classified this recall as Class II, indicating a situation in which use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- 5% Dextrose and 0.9% Sodium Chloride Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7941-09.
- Manufacturer
- Hospira Inc.
- Category
- Drug — IV Fluids
- Affected units
- 340,272
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot # 32-104-JT
- Exp. 08/15 Lot # 34-136-JT
- Exp. 10/15 Lot # 36-092-JT
- Exp. 12/15
Distribution
Part of a larger recall action
This product is one of 11 recalled by Hospira Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 11 products in this recall →Related recalls
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · sterility compromise
See all →- SevereSpectra Medical Devices Recalls Sodium Chloride Injection Ampules Due to Sterility Concerns
FDA (Devices) · 2026-08-19
- HighStryker Recalls Ahto Dual Spike Tube Set Due to Leaking Handpiece
FDA (Devices) · 2026-08-12
- HighIntramedullary Bone Saw Blade Assembly Recalled Due to Potential Sterile Barrier Damage
FDA (Devices) · 2026-08-12
- ModerateIntramedullary Bone Saw Blade Assembly Recalled Due to Potential Sterile Barrier Damage
FDA (Devices) · 2026-08-12
- HighIntramedullary Bone Saw Blade Assemblies Recalled Due to Potential Packaging Damage
FDA (Devices) · 2026-08-12